2023 Was a tough 12 months with the biopharma market, with quite a few businesses downsizing and restructuring their workforces to stay afloat. There are actually indications of Restoration, as mergers and acquisitions picked up across the pharmaceutical and lifestyle sciences market while in the latter Section of 2023 and https://sites.google.com/view/bio-sites/blog